Guidelines of treatment for non-bleeding peptic ulcer disease
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Cheung D.Y. | - |
dc.contributor.author | Jung H.Y. | - |
dc.contributor.author | Song H.J. | - |
dc.contributor.author | Jung S.W. | - |
dc.contributor.author | Jung H.C. | - |
dc.date.available | 2020-11-03T09:45:13Z | - |
dc.date.issued | 2009 | - |
dc.identifier.issn | 1598-9992 | - |
dc.identifier.issn | 2233-6869 | - |
dc.identifier.uri | https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/16544 | - |
dc.description.abstract | Over the past century, since the introduction of non steroidal anti-inflammatory drugs (NSAID), antacid, histamine H2-receptor antagonists (H2RA), proton pump inhibitors (PPI), and discovery of Helicobacter pylori infection, the paradigm of peptic ulcer disease has changed with marked decrease in morbidity and mortality. However, peptic ulcer disease still occupies a position as a major health problem with increase of aged population and NSAIDs usage. In daily general practice, the management of peptic ulcer disease is directed according to the presence of bleeding or not. For non-bleeding peptic ulcer disease, proper acid suppression and the correction of underlying causes such as Helicobacter pylori infection and NSAID use is the main stay of treatment. Though a complete understanding of pathophysiology and a perfect treatment strategy are still a challenge, this guideline aims to provide practical recommendations based on evidences or consensus of experts through in-depth literature review and expert meeting. | - |
dc.format.extent | 13 | - |
dc.language | 한국어 | - |
dc.language.iso | KOR | - |
dc.title | Guidelines of treatment for non-bleeding peptic ulcer disease | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.doi | 10.4166/kjg.2009.54.5.285 | - |
dc.identifier.scopusid | 2-s2.0-75349083862 | - |
dc.identifier.bibliographicCitation | The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, v.54, no.5, pp 285 - 297 | - |
dc.citation.title | The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi | - |
dc.citation.volume | 54 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 285 | - |
dc.citation.endPage | 297 | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART001392296 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordPlus | antacid agent | - |
dc.subject.keywordPlus | antihistaminic agent | - |
dc.subject.keywordPlus | antiulcer agent | - |
dc.subject.keywordPlus | bismuth | - |
dc.subject.keywordPlus | nonsteroid antiinflammatory agent | - |
dc.subject.keywordPlus | proton pump inhibitor | - |
dc.subject.keywordPlus | article | - |
dc.subject.keywordPlus | Helicobacter infection | - |
dc.subject.keywordPlus | Helicobacter pylori | - |
dc.subject.keywordPlus | human | - |
dc.subject.keywordPlus | peptic ulcer | - |
dc.subject.keywordPlus | practice guideline | - |
dc.subject.keywordPlus | Antacids | - |
dc.subject.keywordPlus | Anti-Inflammatory Agents, Non-Steroidal | - |
dc.subject.keywordPlus | Anti-Ulcer Agents | - |
dc.subject.keywordPlus | Bismuth | - |
dc.subject.keywordPlus | Helicobacter Infections | - |
dc.subject.keywordPlus | Helicobacter pylori | - |
dc.subject.keywordPlus | Histamine Antagonists | - |
dc.subject.keywordPlus | Humans | - |
dc.subject.keywordPlus | Peptic Ulcer | - |
dc.subject.keywordPlus | Proton Pump Inhibitors | - |
dc.subject.keywordAuthor | Peptic ulcer | - |
dc.subject.keywordAuthor | Non-bleeding | - |
dc.subject.keywordAuthor | Treatment | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265
COPYRIGHT 2020 KOREA UNIVERSITY MEDICAL LIBRARY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.